Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$14.61 USD
+0.20 (1.38%)
Updated Aug 23, 2024 03:49 PM ET
After-Market: $14.40 -0.21 (-1.44%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
ASMB 14.61 +0.20(1.38%)
Will ASMB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ASMB
Are Medical Stocks Lagging Entera Bio (ENTX) This Year?
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
TEVA Shares Rise on Broad Support for Opioids Settlement
After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB)
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why
Other News for ASMB
Eleven option delistings on August 19th
H.C. Wainwright Remains a Hold on Assembly Biosciences (ASMB)
ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024
Assembly Biosciences: Q2 Earnings Snapshot
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates